Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 11 results:
Author [ Title(Desc)] Type Year
Filters: Author is Lunt, M.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
S. R. Pye, Sheppard, T., Joseph, R. M., Lunt, M., Girard, N., Haas, J. S., Bates, D. W., Buckeridge, D. L., van Staa, T. P., Tamblyn, R., and Dixon, W. G., “Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 781-788, 2018.
C
T. Sheppard, Tamblyn, R., Abrahamowicz, M., Lunt, M., Sperrin, M., and Dixon, W. G., “A comparison of methods for estimating the temporal change in a continuous variable: Example of HbA1c in patients with diabetes”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 1474-1482, 2017.
E
M. J. Cook, Sorial, A. K., Lunt, M., Board, T. N., and O'Neill, T. W., “Effect of timing and duration of statin exposure on risk of hip or knee revision arthroplasty: a population-based cohort study”, J Rheumatol, 2019.
R. M. Joseph, van Staa, T. P., Lunt, M., Abrahamowicz, M., and Dixon, W. G., “Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data”, Pharmacoepidemiol Drug Saf, 2018.
R. M. Joseph, van Staa, T. P., Lunt, M., Abrahamowicz, M., and Dixon, W. G., “Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data”, Pharmacoepidemiol Drug Saf, vol. 28, pp. 179-186, 2019.
H
R. J. Black, Joseph, R. M., Brown, B., Movahedi, M., Lunt, M., and Dixon, W. G., “Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study”, Arthritis Res Ther, vol. 17, p. 375, 2015.
O
M. Movahedi, Costello, R., Lunt, M., Pye, S. R., Sergeant, J. C., and Dixon, W. G., “Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study”, Eur J Epidemiol, vol. 31, pp. 1045-1055, 2016.
P
R. Parisi, Rutter, M. K., Lunt, M., Young, H. S., Symmons, D. P. M., Griffiths, C. E. M., and Ashcroft, D. M., “Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink”, J Invest Dermatol, vol. 135, pp. 2189-2197, 2015.
Q
J. H. Humphreys, Warner, A., Costello, R., Lunt, M., Verstappen, S. M. M., and Dixon, W. G., “Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate”, Ann Rheum Dis, vol. 76, pp. 1509-1514, 2017.
R
Z. Z. N. Yiu, Parisi, R., Lunt, M., Warren, R. B., Griffiths, C. E. M., Langan, S. M., and Ashcroft, D. M., “Risk of Hospitalisation and Death due to Infection in People with Psoriasis: a Population-based Cohort Study using the Clinical Practice Research Datalink”, Br J Dermatol, 2020.
T
M. Jani, B. Yimer, B., Sheppard, T., Lunt, M., and Dixon, W. G., “Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study”, PLoS Med, vol. 17, p. e1003270, 2020.
[Page last reviewed 6 April 2021]